Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials

Journal of Clinical Oncology

Volumn 24, Issue 13, 2006, Pages 2028-2037

  Wapnir, Irene L ^a   Anderson, Stewart J ^a   Mamounas, Eleftherios P ^a   Geyer Jr , Charles E ^a   Jeong, Jong Hyeon ^a   Tan Chiu, Elizabeth ^a   Fisher, Bernard ^a   Wolmark, Norman ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; AGED; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY;

ADULT; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, ESTROGEN;

EID: 33646454600     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.3273     Document Type: Article

References (59)

1. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
2. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002
3. van Dongen JA, Voogd AC, Fentiman IS, et al: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92:1143-1150, 2000
4. Blichert-Toft M, Rose C, Andersen JA, et al: Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis - Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr 11:19-25, 1992
5. Jacobson JA, Danforth DN, Cowan KH, et al: Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332:907-911, 1995
6. Sarrazin D, Le MG, Arriagada R, et al: Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 14:177-184, 1989
7. Fisher B, Wickerham DL, Deutsch M: Breast tumor recurrence following lumpectomy with and without breast irradiation: An overview of recent NSABP findings. Semin Surg Oncol 8:153-160, 1992
8. Fisher B, Anderson S, Fisher ER, et al: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338:327-331, 1991
9. Veronesi U, Marubini E, Del Vecchio M, et al: Local recurrences and distant metastases after conservative breast cancer treatments: Partly independent events. J Natl Cancer Inst 87:19-27, 1995
10. Stotter A, Atkinson EN, Fairston BA, et al: Survival following locoregional recurrence after breast conservation therapy for cancer. Ann Surg 212:166-172, 1990
11. Haffty BG, Fischer D, Beinfield M, et al: Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys 21:293-298, 1991
12. Abner AL, Recht A, Eberlein T, et al: Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 11:44-48, 1993
13. Whelan T, Clark R, Roberts R, et al: Ipsilateral breast tumor recurrence post lumpectomy is predictive of subsequent mortality: Results from a randomized trial. Int J Radiat Oncol Biol Phys 30:11-16, 1994
14. Haffty BG, Reiss M, Beinfield M, et al: Ipsilateral breast tumor recurrence as a predictor of distant disease: Implications for systemic therapy at the time of local relapse. J Clin Oncol 14:52-57, 1996
15. Touboul E, Buffat L, Belkacemi Y, et al: Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43:25-38, 1999
16. Freedman GM, Fowble BL: Local recurrence after mastectomy or breast-conserving surgery and radiation. Oncology 14:1561-1581, 2000
17. Fisher B, Brown AM, Dimitrov NV, et al: Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: Results from the National Surgical Adjuvant Breast and Bowel Project B-15. J Clin Oncol 8:1483-1496, 1990
18. Fisher B, Redmond C, Legault-Poisson S, et al: Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: Results from the National Surgical Adjuvant Breast and Bowel Project B-16. J Clin Oncol 8:1005-1018, 1990
19. Fisher B, Brown A, Mamounas E, et al: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483-2493, 1997
20. Fisher B, Anderson S, Wickerham DL, et al: Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-22. J Clin Oncol 15:1858-1869, 1997
21. Fisher B, Anderson S, DeCillis A, et al: Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-25. J Clin Oncol 17:3374-3388, 1999
22. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16:1141-1154, 1988
23. Cox D: Regression models and life tables. J R Stat Soc B 30:248-275, 1972
24. Kaibfleisch JP, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley and Sons, 1980
25. Kaplan EL, Meier P: Nonparamethc estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
26. Gail MH: Evaluating serial cancer marker studies in patients at risk of recurrent disease. Biometrics 37:67-78, 1981
27. Clarke DH, Le MG, Sarrazin D, et al: Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: Experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11:137-145, 1985
28. Fortin A, Larochelle M, Laverdiere J, et al: Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 17:101-109, 1999
29. Kurtz JM, Amalric R, Brandone H, et al: Local recurrence after breast-conserving surgery and radiotherapy: Frequency, time course, and prognosis. Cancer 63:1912-1917, 1989
30. Moran MS, Haffty BG: Local-regional breast cancer recurrence: Prognostic groups based on patterns of failure. Breast J 8:81-87, 2002
31. Calle R, Vilcoq JR, Zafrani B, et al: Local control and survival of breast cancer treated by limited surgery followed by irradiation. Int J Radiat Oncol Biol Phys 12:873-878, 1986
32. Arriagada R, Le MG, Contesso G, et al: Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 13:1404-1413, 2002
33. Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 355:1757-1770, 2000
34. Fowble BL, Schultz DJ, Overmoyer B, et al: The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 30:23-33, 1994
35. Voogd AC, Nielsen M, Peterse JL, et al: Differences in risk factors for local and distant recurrence after breast conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials. J Clin Oncol 19:1688-1697, 2001
36. Recht A, Connolly JL, Schnitt SJ, et al: The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 14:3-10, 1988
37. Dalberg K, Mattsson A, Rutqvist LE, et al: Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences. Breast Cancer Res Treat 43:73-86, 1997
38. Kurtz JM, Spitalier JM, Amalric R, et al: Mammary recurrence in women younger than forty. Int J Radiat Oncol Biol Phys 15:271-276, 1988
39. Elkhuizen PH, van Slooten HJ, Clahsen PC, et al: High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol 18:1075-1083, 2000
40. Fisher ER, Anderson S, Redmond C, et al: Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: Pathological findings from NSABP protocol B-06. Semin Surg Oncol 8:161-166, 1992
41. Elkhuizen PH, Voogd AC, van den Broek LC, et al: Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: A case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys 45:73-83, 1999
42. Schnitt SJ, Connolly JL, Harris JR, et al: Pathologic predictors of early local recurrence in stage I and II breast cancer treated by primary radiation therapy. Cancer 53:1049-1057, 1984
43. Smitt MC, Nowels KW, Zdeblick MJ, et al: The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76:259-267, 1995
44. Park CC, Mitsumori M, Nixon A, et al: Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18:1668-1675, 2000
45. Singletary SE: Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184:383-393, 2002
46. Meric F, Mirza NO., Vlastos G, et al: Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97:926-933, 2003
47. Fisher ER, Sass R, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6): II. Relation of local breast recurrence to multicentricity. Cancer 57:1717-1724, 1986
48. Frediksson I, Liljergren G, Amesson L, et al: Local recurrence in the breast after conservative surgery: A study of prognosis and prognostic factors in 391 women. Eur J Cancer 38:1860-1870, 2002
49. Kurtz JM, Jacquemier J, Brandone H, et al: Inoperable recurrence after breast-conserving surgical treatment and radiotherapy. Surg Gynecol Obstet 172:357-361, 1991
50. Gage I, Schnitt SJ, Recht A, et al: Skin recurrences after breast-conserving therapy for early-stage breast cancer. J Clin Oncol 16:480-486, 1998
51. Smith TE, Lee D, Turner BC, et al: True recurrence versus new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48:1281-1289, 2000
52. Huang E, Buchholz TA, Meric F, et al: Classifying local disease recurrences after breast conservation therapy based on location and histology: New primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95:2059-2067, 2002
53. Kurtz JM, Amalric R, Brandone H, et al: Results of wide excision for mammary recurrence after breast-conserving therapy. Cancer 61:1969-1972, 1988
54. Kurtz JM, Jacquemier J, Amalric R, et al: Is breast conservation after local recurrence feasible? Eur J Cancer 27:240-244, 1991
55. Mullen EE, Deutsch M, Bloomer WD: Salvage radiotherapy for local failures of lumpectomy and breast irradiation. Radiother Oncol 42:25-29, 1997
56. Deutsch M: Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation. Int J Radiat Oncol Biol Phys 53:687-691, 2002
57. Kuerer HM, Arthur DW, Haffty BG: Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: The potential role of partial breast irradiation. Cancer 100:2269-2280, 2004
58. Borner M, Bacchi M, Goldhirsch A, et al. First isolated locoregional recurrence following mastectomy for breast cancer: Results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation - Swiss Group for Clinical Cancer Research. J Clin Oncol 12:2071-2077, 1994
59. Waeber M, Castiglione-Gertsch M, Dietrich B, et al: Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: Definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Ann Oncol 14:1215-1221, 2003